Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Jain

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Transplantation and Cellular Therapy|February 14, 2022
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for MyelofibrosisTania Jain, Hua-Ling Tsai, Amy E DeZern, et al.
Leukemia|May 15, 2024
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysisTrent P Wang, Kwang W Ahn, Mazyar Shadman, et al.
The Journal of Clinical Investigation|September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantationGunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
Transplantation and Cellular Therapy|September 23, 2020
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular TherapyBhagirathbhai Dholaria, Bipin N Savani, Betty K Hamilton, et al.
Haematologica|May 8, 2025
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapyJonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.
Blood Advances|October 20, 2020
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamideJonathan A Webster, Leo Luznik, Hua-Ling Tsai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Haris Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
Transplantation Direct|December 30, 2021
Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 TherapeuticsAfrah S Sait, Teresa Po-Yu Chiang, Kieren A Marr, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Transplantation and Cellular Therapy|February 14, 2022
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for MyelofibrosisTania Jain, Hua-Ling Tsai, Amy E DeZern, et al.
Leukemia|May 15, 2024
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysisTrent P Wang, Kwang W Ahn, Mazyar Shadman, et al.
The Journal of Clinical Investigation|September 8, 2020
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantationGunjan L Shah, Susan DeWolf, Yeon Joo Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Prithviraj Bose, et al.
Transplantation and Cellular Therapy|September 23, 2020
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular TherapyBhagirathbhai Dholaria, Bipin N Savani, Betty K Hamilton, et al.
Haematologica|May 8, 2025
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapyJonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.
Blood Advances|October 20, 2020
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamideJonathan A Webster, Leo Luznik, Hua-Ling Tsai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyAaron T Gerds, Jason Gotlib, Haris Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024Jason Gotlib, Aaron T Gerds, Peter Abdelmessieh, et al.
Transplantation Direct|December 30, 2021
Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 TherapeuticsAfrah S Sait, Teresa Po-Yu Chiang, Kieren A Marr, et al.
Pageof 12